Curing HIV
Published on September 28, 2015“The time is now."
“The time is now."
“The time is now. The field is ready for new advances toward curing HIV,” said Dr. Myron Cohen, director of the UNC Institute for Global Health & Infectious Diseases.
UNC has long been recognized for its work in preventing and treating HIV, but with a landmark collaboration with GSK, the University will accelerate research to cure HIV/AIDS.
Together, the HIV Cure center and Qura Therapeutics, a new jointly-owned company that will handle the business side of the partnership, will work to eradicate HIV worldwide.
“Once industry invests in a problem, it catalyzes reactions that are predictable and unpredictable,” said Cohen. “I am really sure that the partnership will lead to visible, demonstrable, important changes in the way we treat HIV infection.”
This is story number 190 in the Carolina Stories 225th Anniversary Edition magazine.
